Andrew Derodra

Plus aucun poste en cours

59 ans

Health Technology

Consumer Non-Durables

Consumer Services

Profil

Andrew Derodra served as the Chief Financial Officer & Executive Director at SkyePharma Plc and as the Director-Business Transformation at ABI SAB Group Holding Ltd. He also worked as the Vice President-Finance & Control at Tate & Lyle Plc.
From 2016 to 2018, he served as the Chief Financial Officer & Director at Vectura Group Ltd. Mr. Derodra completed his undergraduate degree at the University of Oxford.

Anciens postes connus de Andrew Derodra

Sociétés	Poste	Fin
VECTURA GROUP	Directeur Financier/CFO	31/07/2018
SABMILLER PLC	Corporate Officer/Principal	-
TATE & LYLE PLC	Corporate Officer/Principal	-
SKYEPHARMA PLC	Directeur Financier/CFO	-

Voir l'expérience en détail de Andrew Derodra

Formation de Andrew Derodra

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Andrew Derodra

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	5
SkyePharma Plc SkyePharma Plc Pharmaceuticals: OtherHealth Technology Manufactures and develops oral and inhalation pharmaceutical products	Health Technology
ABI SAB Group Holding Ltd. ABI SAB Group Holding Ltd. Beverages: AlcoholicConsumer Non-Durables Engages in manufacturing and distributing beers and beverages	Consumer Non-Durables
Vectura Group Ltd. Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures inhalation drugs and medical devices	Health Technology
Tate & Lyle Plc Tate & Lyle Plc Food: Specialty/CandyConsumer Non-Durables Manufactures sweeteners, industrial starches and ingredients	Consumer Non-Durables
University of Oxford University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services